[1]
“Review of immune-metabolic studies and re-purposed treatments of Nigerian COVID-19 patients: A pointer to mild, gender- and age-based status of admitted patients”, NJPS, vol. 39, no. 2, pp. 177–183, Dec. 2024, doi: 10.54548/njps.v39i2.2.